Discontinued Operations (Tables)

12 Months Ended

Sep. 30, 2013

Discontinued Operations And Disposal Groups [Abstract]

Operating Results from Discontinued Operations

The following is a summary of the operating results of SurModics Pharmaceuticals discontinued operations for the years ended September 30 (in thousands):

	2013			2012			2011
Total revenue	$	—		$	5,297		$	15,109
Income (loss) from discontinued operations	$	1,136		$	2,309		$	(43,197	)
Income tax (provision) benefit		(548	)		(1,133	)		13,766
Income (loss) from discontinued operations, net of income taxes	$	588		$	1,176		$	(29,431	)
Loss on sale of discontinued operations	$	—		$	(1,691	)	$	—
Income tax benefit		—			617			—
Loss on sale of discontinued operations, net of income taxes	$	—		$	(1,074	)	$	—

Assets and Liabilities of Discontinued Operations

The major classes of assets and liabilities of discontinued operations as of September 30 were as follows (in thousands):

	2013		2012
Accounts receivable, net	$	—	$	283
Other current assets		46		600
Current assets of discontinued operations		46		883
Total assets of discontinued operations	$	46	$	883
Other current liabilities payable	$	139	$	1,640
Current liabilities of discontinued operations		139		1,640
Total liabilities of discontinued operations	$	139	$	1,640